DSHS Statement on Texas Residents Who Were on Board the MV Hondius

Translate to Spanish or other 102 languages!

The Centers for Disease Control and Prevention has notified DSHS that two Texas residents were passengers on the MV Hondius, a ship that experienced an outbreak of hantavirus while traveling in the Atlantic Ocean. Image:  Stefan Brending / Lizenz: Creative Commons CC-BY-SA-3.0 de
The Centers for Disease Control and Prevention has notified DSHS that two Texas residents were passengers on the MV Hondius, a ship that experienced an outbreak of hantavirus while traveling in the Atlantic Ocean. Image:  Stefan Brending / Lizenz: Creative Commons CC-BY-SA-3.0 de
- Advertisement -

The Centers for Disease Control and Prevention has notified DSHS that two Texas residents were passengers on the MV Hondius, a ship that experienced an outbreak of hantavirus while traveling in the Atlantic Ocean. The passengers left the ship and returned to the United States before the outbreak was identified.

Public health workers in Texas have reached the two individuals, and they report they are not experiencing any symptoms and did not have any contact with a sick person while aboard the ship. They have agreed to monitor themselves for symptoms with daily temperature checks and contact public health officials at any sign of a possible illness.

Hantaviruses are usually spread through contact with wild rodent droppings or urine. The strain in the Hondius outbreak, Andes virus, can spread from person to person in limited circumstances. It typically requires close, prolonged contact with a person who is actively sick with the disease. It is not known to spread through casual contact such as shaking hands or being in the same room for a few minutes. There have been no documented cases where a person without symptoms spread it to someone else.

- Advertisement -

DSHS will not release additional personal details about the passengers in order to protect their privacy.

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

FDA Approves First Factor Xla Inhibitor to Help Prevent Stroke in Certain Adults at High Risk 

The U.S. Food and Drug Administration today approved Sunharbo (asundexian) 50 mg tablets, the first factor XIa (FXIa) inhibitor for use in combination with antiplatelet therapy to reduce the risk of stroke in adults following a recent mild-to-moderate non-cardioembolic ischemic stroke (a stroke caused by a clot that did not originate in the heart) or a high-risk transient ischemic attack (TIA), often called a “mini-stroke.” 

Practical Health Tips to Navigate Cold and Flu Season Safely

With cold and flu season in full swing, experts say there are some simple steps you can take to protect yourself and those around you.

DHR Health Expands Ophthalmology Services with Addition of Dr. Rachel Gelman

 Continuing its mission to provide exceptional medical care to patients across the Rio Grande Valley, DHR Health is pleased to welcome ophthalmologist Dr. Rachel Gelman to its team of healthcare providers.

STHS McAllen Welcomes Aspiring Youth for an Interactive Look Inside Healthcare

As the demand for healthcare professionals continues to grow, introducing young students to the wide range of opportunities available in the medical field is more important than ever. From nurses and physicians to emergency responders, pharmacists and other essential healthcare workers, each plays a critical role in caring for patients and keeping communities healthy.
- Advertisement -